Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.

This study has been completed.
Information provided by:
Celgene Identifier:
First received: April 27, 2006
Last updated: September 28, 2009
Last verified: September 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2009
  Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: September 28, 2009